Dow Jones Futures Reverse Lower On Hot Inflation Data; Tesla Stock Falls Before AI Day Could We Get a double reverse!
TWO BUYS: A) DICE Therapeutics, Inc. (DICE) NasdaqGM - NasdaqGM Real Time Price. 19.65+0.46(+2.40%) B) Confluent, Inc. (CFLT) NasdaqGS - NasdaqGS Real Time Price. 23.25-0.55(-2.31%) At close: September 29 04:00PM EDT 23.44+0.19(+0.82%) Pre-Market:08:43AM EDT Crazy story. Big party lots of folks for Big Pete's 60th. I did not go. Guy there drank 3 or 4 glasses of red wine. Legs went paralyzed. I shit you not guy had to be carried from the table, he wet himself, and hidden from his wife for hours until the next morning when he regained his ability to walk. Apparently he's not supposed to drink at all. Alcohol paralysis<-- have you veer heard of such a thing!
The whales have completed their window dressing for Q4. A little more churn and the VZ rally should begin. 4476 S&P target by year end.
THIS MIGHT BE INTERESTING VAN OCUL. BELIEVE THIS WAS ANAME OF YOURS WAY BACK- THEY HAVE AN IMPLANT I BELIEVE WHICH REQUIRES ONE INJECTION INTO THE EYE OWCH. BUT THEN IT'S GOOD ... THEY HAD NEWS 3 DAYS AGO BUT THE STOCK ONLY MOVED YEST OR TODAY AND HAD SOME BIG VOL STICKS. I HAVE TO DO SOME MORE WORK ON THIS BUT WATCH Ocular Therapeutix, Inc. (OCUL) NasdaqGM - NasdaqGM Real Time Price. 4.7600-0.3700(-7.21%)<-------------------------- As of 10:06AM LOOK FOR INSIDER/ CASH BURN ETC...
INTERESTING ACTION))) OCUL THURS MORN & AFT $4.04 THURS 3:45 $5.13!<----- WTF. MARKET WAS DEEP DIVING YESTERDAY AND THIS GOES UP AT THE END OF THE DAY....
A HA! Ocular Therapeutix data 'paint a compelling profile,' says Piper Sandler 16:33 OCUL After Ocular Therapeutix presented additional details from the Phase Ib randomized study of OTX-TKI versus aflibercept in wAMD at Eyecelerator, Piper Sandler analyst Joseph Catanzaro note that the presentation included a detailed swimmer's plot that "clearly showed" the extent of injection burden for the 12-months prior to study enrollment and the subsequent 93% reduction in treatment burden while on study. The analyst, who contends that the added data "paint a compelling profile" and "further solidify OTX-TKI as what we already saw as a best-in-class program," keeps an Overweight rating and $10 price target on Ocular shares.
S&P 500 (^GSPC) SNP - SNP Real Time Price. 3,654.81+14.34 As of 10:39AM EDT. THANK YOU STONEY! Confluent, Inc. (CFLT) NasdaqGS - NasdaqGS 24.87+1.62(+6.97%)<------------------ As of 10:39AM EDT.